Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ImPRoving OutcoMes in Individuals at Clinical High Risk fOr Psychosis Using Cannabidiol: a Double-blind, Randomised conTrollEd Trial

NCT07434973 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT07434973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07434973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ImPRoving OutcoMes in Individuals at Clinical High Risk fOr Psychosis Using Cannabidiol: a Double-blind, Randomised conTrollEd Trial
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
December 1, 2031
Enrollment
586 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high risk for developing psychosis, clinical high risk for psychosis, clinical high risk for psychosis (chr)